冷冻保存动脉同种异体移植物与肝素涂层血管移植物在膝下旁路术中的比较
这项回顾性研究在2所大学医院纳入41例慢性肢体威胁性缺血患者,在缺乏合适大隐静脉时分别使用冷冻保存动脉同种异体移植物(CAA,24例)或肝素涂层假体(HBP,17例)行膝下旁路术。CAA组12个月一期和二期通畅率分别为52%和61%,HBP组为88%和94%,差异无统计学意义;CAA组手术时间显著更长。结论认为CAA并不优于HBP。
要点
- CAA与HBP在膝下旁路术中的通畅率和无截肢生存率无显著差异。
- WIfI 4期是移植物血栓形成和重大截肢的显著危险因素。
- CAA组手术时间显著更长,可能不值得额外成本和手术时长。
核心结论
- 在慢性肢体威胁性缺血患者的膝下旁路术中,冷冻保存动脉同种异体移植物不优于肝素涂层假体,可能不值得额外成本和更长手术时间。
研究设计与样本
- 回顾性研究,在2所大学医院纳入41例连续治疗的慢性肢体威胁性缺血患者。
- 在缺乏合适大隐静脉时,24例使用冷冻保存动脉同种异体移植物,17例使用肝素涂层假体行膝下旁路术。
- 采用Kaplan-Meier分析比较一期和二期通畅率及无截肢生存率,采用二项逻辑回归分析重大截肢和血栓形成的危险因素。
主要发现
- CAA组平均随访18.5个月(±14.3),HBP组平均随访17.6个月(±6.1)。
- CAA组12个月一期和二期通畅率分别为52%(±10.6)和61%(±10.3),HBP组分别为88%(±7.8)和94%(±5.7),差异无统计学意义(P=0.27和P=0.28)。
- 移植物血栓形成的显著因素包括WIfI分类4期(风险高6倍,P=0.04)和远端吻合于腿动脉(血栓风险高9倍,P=0.03)。
- 18个月无截肢生存率两组相似(CAA:75%±9 vs HBP:94%±6,P=0.11)。
- WIfI 4期患者接受重大截肢的比值比是WIfI 2或3期患者的13倍(95%CI,1.16-160.93;P=0.04)。
临床怎么用
- 在缺乏合适大隐静脉的慢性肢体威胁性缺血患者中,选择膝下旁路移植物时需权衡CAA与HBP的通畅率、成本和手术时间。
- WIfI 4期患者术后移植物血栓形成和重大截肢风险显著增高,应加强监测和干预。
- 远端吻合于腿动脉与血栓形成风险增高相关,术中应予以关注。
局限性
- 回顾性研究设计。
- 样本量较小(41例)。
- 随访时间较短(平均约18个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to compare cryopreserved arterial allograft (CAA) to heparin-bonded prosthesis (HBP) in infragenicular bypasses for patients with chronic limb-threatening ischemia (CLTI). METHODS: This retrospective study took place in 2 university hospitals and included 41 consecutive patients treated for CLTI. In the absence of a suitable saphenous vein, an infragenicular bypass was performed using either CAA (24 cases) or HBP (17 cases). Kaplan-Meyer analysis compared primary and secondary patency and amputation-free survival rates. Binomial logistic regression analyzed risk factors for major amputation and thrombosis. RESULTS: The mean followup was 18.5 months (±14.3) in the CAA group, 17.6 (±6.1) in the HBP group. In the CAA group, primary and secondary patency rates at 12 months were 52% (±10.6) and 61% (±10.3), compared to 88% (±7.8) and 94% (±5.7) in the HBP group, respectively. The difference in patency rates was not statistically different (P = 0.27 and P = 0.28, respectively). The statistically significant factors of graft thrombosis were, a stage 4 from the WIfI classification (Wound Ischemia foot Infection) with a 6 times higher risk (P = 0.04), and a distal anastomosis on a leg artery with a 9 times higher risk of thrombosis (P = 0.03). Amputation-free survival rates at 18 months were similar between the groups (CCA: 75% (±9) versus HBP: 94% (±6), P = 0.11). Patients classified as WIfI stage 4 had 13 times higher odds to undergo major amputation than patients with WIfI stage 2 or 3 (95% CI, 1.16-160.93; P = 0.04). The intervention was longer in the CCA group of 74 min (278 min ± 86) compared to the HBP group (203 min ± 69). This difference was statistically significant (95% CI, 17.86-132.98), t(35) = 2.671, P = 0.01. CONCLUSIONS: CCA is not superior to HBP in infragenicular bypasses for CLTI, and may not be worth the extra cost and the longer operative duration.
引用
- Hirth-Voury A, Massiot N, Giauffret E, et al. Comparison of Cryopreserved Arterial Allografts Versus Heparin-bonded Vascular Grafts in Infragenicular Bypass for Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2019. PMID: 31629123. doi:10.1016/j.avsg.2019.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。